Adropin Drives Glycolysis and EMT in Pancreatic Cancer via β₂-AR/β-Arrestin 2/ERK Signaling
A new study shows that the metabolic peptide Adropin promotes glycolytic reprogramming and EMT in pancreatic cancer through β₂-adrenergic receptor, ...
A new study shows that the metabolic peptide Adropin promotes glycolytic reprogramming and EMT in pancreatic cancer through β₂-adrenergic receptor, ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.